Blog | HemaCare

DARTs-Targeting the Elimination of HIV-Infection

Sep 7, 2016 3:42:11 PM / by Stacy Matthews Branch, DVM, PhD posted in CD4, CD4+ helper T cells, Cytotoxic T Cells, HIV, research

0 Comments

Available therapies used to prevent the development of AIDS in HIV-infected individuals work by reducing the level of infection, but do not completely destroy the infection. A persistent source of HIV-infected cells remains in HIV-infected individuals despite being on long-term antiviral therapy. This causes ongoing inflammation and immune system activation, putting these individuals at risk for developing non-AIDS diseases and conditions. Given the increased risk of health with the persistent presence of HIV-infected cells, new treatment approaches are needed that will completely eliminate or kill the HIV-infected cells, removing the source (reservoir) of these cells.

Read More

HIV Research Marches on With Exciting Leads

Mar 11, 2015 1:00:54 PM / by James Sanchez posted in CCR5, CD4, research, vaccines

0 Comments

HemaCare reports 3 recent findings generating enthusiasm in the HIV research community

Read More

The Shingles Vaccine: A Shot at Wellbeing in Aging Adults with Fewer T Cells

Feb 11, 2015 1:00:01 PM / by Daisy posted in CD4, chicken pox, research, shingles, shingles vaccine, varicella zoster virus

0 Comments

Our immune cells, including T cells, decline as we age. Shingles vaccination aids our diminished immune systems in keeping the chicken pox virus dormant.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts